1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 2:Preoperative rCBF in groups I and II
Baseline rCBF (mL/100 g/min) Postacetazolamide rCBF (mL/100 g/min) Ipsilateral P Contralateral P Ipsilateral P Contralateral P Group I 39.9 ± 6.0 NS 41.5 ± 6.1 NS 44.8 ± 8.7* .002 50.3 ± 9.7 NS Group II 42.5 ± 5.0 42.6 ± 5.5 53.2 ± 8.8# 55.5 ± 9.2
Note:—rCBF indicates regional cerebral blood flow. Groups I and II were determined by poststenotic blood flow below and above 3.5 mL/s, respectively. The differences between the values in groups I and II were analyzed by unpaired t test. NS indicates not significant.
* P < .0001,
# P < .05 versus contralateral rCBF, paired t test.